IL10 and neoplasm: In a study of glioblastomas by Ravi et al. [93], using Spotlight [94], they reported that HMOX1+ myeloid cells releasing IL-10 were spatially located in the mesenchymal tumor area, which could induce exhausted T cells, thereby promoting an immunosuppressive TME.